12.55 -0.06 (-0.48%) | 04-24 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 15.07 | 1-year : | 15.6 |
Resists | First : | 12.9 | Second : | 13.35 |
Pivot price | 12.48 | |||
Supports | First : | 12.18 | Second : | 10.13 |
MAs | MA(5) : | 12.59 | MA(20) : | 12.62 |
MA(100) : | 12.46 | MA(250) : | 12.73 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 51.1 | D(3) : | 49.1 |
RSI | RSI(14): 46.9 | |||
52-week | High : | 14.75 | Low : | 9.76 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ THW ] has closed below upper band by 39.9%. Bollinger Bands are 21.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 12.68 - 12.75 | 12.75 - 12.81 |
Low: | 12.36 - 12.45 | 12.45 - 12.52 |
Close: | 12.42 - 12.55 | 12.55 - 12.66 |
Tekla World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector. For its fixed income portion, the fund primarily invests in corporate debt securities. Tekla World Healthcare Fund was formed on June 26, 2015 and is domiciled in the United States.
Fri, 05 Apr 2024
(THW) Technical Data - Stock Traders Daily
Tue, 02 Apr 2024
Repurposed Cancer Drugs May Improve Tuberculosis Treatment | Harvard Medical School - Harvard Medical School
Thu, 21 Mar 2024
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ ... - Yahoo Finance
Mon, 30 Oct 2023
abrdn completes acquisition of US specialist healthcare closed-end funds - Investment Week
Mon, 30 Oct 2023
THW: abrdn Takes Over, But THQ Still Looking Better - Seeking Alpha
Fri, 27 Oct 2023
abrdn Announces Its Appointment to Four U.S. Specialist Healthcare Closed-End Funds, New Board of Trustees to the ... - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NYSE
|
|
Sector:
Financial Services
|
|
Industry:
Asset Management
|
|
Shares Out | 38 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 11.8 (%) |
Shares Short | 285 (K) |
Shares Short P.Month | 331 (K) |
EPS | -3.54 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | -3.55 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |